← Back to knowledge base

Cannabis Trends & Market Forecasting

Cannabis Trends & Market Forecasting

Market intelligence on emerging categories, trending genetics, breeder ecosystem, legalization pipeline, and growth projections. Combines third-party analyst data (Headset, BDSA, Statista) with first-party Treez platform metrics (~400 orgs, ~$200M/month) for dual-source credibility.

Audience adaptation: This reference serves multiple audiences.

  • For operators: "what to stock and when"
  • For investors: "where's growth and what's the TAM"
  • For consultants: "what to advise clients on"

See also: strains.md for strain profiles | brands.md for brand data | legality.md for state status | pricing.md for price benchmarks | retail-strategy.md for menu optimization | inventory-planning.md for seasonal retail playbook

Vintage: early 2026 | Treez platform data: May 2025 - Mar 2026. When this file is >6 months old, note "based on early-2026 data" and recommend checking current sources.

Summary

This reference covers six interconnected domains of cannabis market intelligence: emerging product categories (beverages, infused pre-rolls, solventless, minor cannabinoids, the All-In-One cartridge format shift), strain trends (lineage families, org-penetration ground truth, currently hot strains, classification dynamics), breeder ecosystem (standalone profiles of the top genetics houses), brand momentum (who is winning by org reach, revenue, SKU breadth, and premium positioning), legalization pipeline (federal rescheduling, interstate commerce scenarios, state pipeline tiers, social equity), and market projections with seasonal forecasting (multi-source TAM ranges, state-level growth, category growth, and a seasonal calendar with real platform-wide multipliers and inventory prep triggers).

The organizing differentiator is dual-source data: every major claim pairs a third-party industry source (Headset, BDSA, Statista, New Frontier, MJBizDaily) with first-party Treez platform data (~400 active orgs, ~$200M/month platform revenue across ~345 active orgs, May 2025 through March 2026). The Treez data grounds analyst narratives in what dispensaries actually sell — not what the industry talks about. Every trend item carries a direction indicator ([Rising], [Stable], [Declining], [Emerging]) so Claude can qualify advice appropriately as data ages.

For deep strain profiles see strains.md. For price benchmark ranges and market-maturity tiers see pricing.md. For current state legal status and licensing see legality.md. For retail menu optimization by positioning see retail-strategy.md. For detailed month-by-month inventory playbooks see inventory-planning.md. For brand-level detail see brands.md.

Data freshness guidance: When trends data is >6 months old, qualify with "based on early-2026 data" and recommend checking current Headset/BDSA reports or a fresh Treez platform pull. Trend direction indicators age more gracefully than point estimates; multipliers and dollar figures are most perishable.

1. Platform Snapshot: What ~400 Dispensaries Actually Sell

Before diving into category trends, ground the discussion in what the Treez platform actually processes each month. This is the closest thing to a "census" of US dispensary transactions available, covering ~345 active orgs and ~$200M/month in GMV (as of March 2026).

Treez platform-wide category revenue shares (as of March 2026):

| Category | Revenue Share | Monthly Revenue | Median Price | Trend | |----------|--------------|-----------------|--------------|-------| | Flower | 33% | ~$64M | $24.49 | [Declining] -- losing share to Cartridge, Preroll | | Cartridge | 28% | ~$56M | $20.88 | [Rising] -- approaching Flower parity | | Preroll | 16% | ~$32M | $8.07 | [Rising] -- infused format driving growth | | Edible | 10% | ~$20M | $11.67 | [Stable] -- steady, beverages outperforming within | | Extract | 5% | ~$10M | $15.99 | [Stable] -- connoisseur niche, Live Rosin segment rising | | Beverage | 1.5% | ~$3M | $6.46 | [Rising] -- small base, +11% YoY industry |

Source: Treez platform (~400 orgs), May 2025 - March 2026 aggregate. Revenue shares are approximate and rounded.

Platform revenue mix summary: Flower 33%, Cartridge 28%, Preroll 16%, Edible 10%, Extract 5%, Beverage 1.5%. Cartridge revenue is approaching Flower — a structural shift that occurred in late 2025 on the Treez platform. Flower remains the largest category by revenue, but its share is declining as Cartridge and Preroll continue to absorb occasions. The same pattern shows up in industry reports (BDSA: CA vape revenue surpassed flower in late 2025), but the Treez data shows the shift is now broad and platform-wide, not just California-concentrated.

Basket norms (Treez first-party): AOV $44-46, median basket $33, 2.7 items per basket, 1.4 categories per basket. Most consumers are single-category shoppers per visit — a signal that cross-sell merchandising (see retail-strategy.md) has more headroom than many operators assume.

2. Emerging Product Categories

Tiered depth per Phase 11 decisions: deep coverage of the four categories with the most market-shaping dynamics, brief coverage of supporting trends.

Cannabis Beverages [Rising]

Industry (Headset / BDSA): Beverages grew +11% YoY, holding ~1% total cannabis dollar share ($54.6M in Q1 2025 per BDSA). Global projection: $1.68B (2025) to $8.08B (2035) at 17% CAGR. The low-dose (<5mg) subsegment is the fastest-growing slice at 33.7% CAGR, driven by alcohol substitution.

Treez platform (~400 orgs): Beverage revenue sits at $2.7-3.3M/month (1.5% of platform revenue), with steady month-over-month growth across the May 2025 - March 2026 window. Median price $6.46 positions beverages as impulse/single-serve. The category has the highest unit velocity of any category at 80.4 units per SKU — dispensaries sell a lot of beverages per SKU, they just don't stock many SKUs (median 80 beverage variants per org, vs. 1,269 for flower).

Catalog quality flag: 65.1% of beverage products on the platform lack classification — the worst fill rate of any category. This is partly because beverages sit awkwardly in Indica/Sativa taxonomy (many are Hybrid or "effect-based"), but it's also a merchandising liability. Only 25.4% of beverages are classified Hybrid, with the remainder scattered across CBD, Indica, Sativa, or Unknown.

Named brands on the Treez platform:

  • Keef — 167 orgs (40.4% penetration), 2,395 variants. Broadest beverage distribution.
  • Cann — 137 orgs (33.2% penetration), 2,588 variants. Low-dose social tonics, major alcohol-substitution positioning.
  • WYLD — 318 orgs (77.0% penetration across all categories). Plays in beverages alongside gummies, strong crossover.
  • Uncle Arnie's, St. Ides — also visible in top-50 penetration; iced-tea and malt-beverage formats.

Positioning notes: Beverages pair best with Edibles in basket analysis (1.4% of all baskets are Beverage+Edible combos) — a "consumption-oriented" buyer segment. Shelf-stability, refrigeration requirements, and state-by-state regulatory divergence remain the key barriers to scale (see legality.md).

Infused Pre-Rolls [Rising]

Industry (Headset / BDSA): Pre-rolls overall grew +12% YoY, the highest CAGR at 10% among established categories. Infused pre-rolls command 43% of the pre-roll category by dollar share. 420 weekend 2025 saw pre-rolls jump +90%.

Treez platform (~400 orgs): Pre-rolls are 16% of platform revenue (~$32M/month). Within the category, infused prerolls hit 46.3% of preroll revenue in March 2026 — higher than the industry 43% figure and approaching parity with flower prerolls (52.9%). Infused is the growth engine; flower prerolls are stable.

Product innovation: Multi-pack formats (5-packs, 10-packs for value segments), hash-infused (higher quality perception), kief-coated (entry-level infusion), diamond-dusted (premium positioning, often 30%+ THC claims).

Named brands on the Treez platform:

  • JEETER — 224 orgs (54.2% penetration), 42,656 products, ~$3.0M/month revenue. Dominant infused preroll brand, riding the category wave.
  • SLUGGERS — 156 orgs (37.8% penetration). Infused baseball-bat format innovation.
  • Presidential — 133 orgs (32.2% penetration).

Occasion signal: Pre-rolls over-index on 4/20 weekend (industry +90%) and holiday weekend occasions — the convenience + shareability combo is what drives the spikes. (See seasonal calendar in Section 8.)

Solventless / Live Rosin [Rising]

Industry (BDSA / Concentrate reports): Rosin sales +8% YoY with +11% product count growth. Solventless extraction methods overall +35% YoY. Average retail price $31/g — a significant premium over solvent-based concentrates. A distinct "connoisseur" consumer profile is emerging (overlapping with craft spirits and single-origin coffee consumers).

Treez platform (~400 orgs): Extract as a category is 5% of revenue (~$10M/month). Within Extract, Live Rosin is 2.5% of total platform products (77,957 products across 381 orgs) — broad distribution for a premium segment. Live Resin (solvent-based) sits at 1.5% of products (46,833 across 364 orgs). Badder, Diamonds, and Extract-General fill out the rest.

Named brands on the Treez platform:

  • 710 LABS — 150 orgs (36.3% penetration), 39,904 products. The largest catalog of any solventless-focused brand on the platform.
  • NASHA — 144 orgs (34.9% penetration). Hash-focused, premium positioning.
  • Fig Farms, Connected, Alien Labs — flower brands that anchor the premium rosin segment via in-house extraction.

Positioning notes: Solventless positioning emphasizes purity (no residual solvents), terpene preservation (lower-temp extraction), and small-batch scarcity. The segment is expanding beyond concentrates into live-rosin gummies and live-rosin vapes — "solventless vape" is an emerging premium niche. (See concentrates-extraction.md for extraction methodology.)

Minor Cannabinoids (CBN, THCV, CBG) [Emerging]

Industry (Rolling Stone / FMI): Minor cannabinoid products grew +65% YoY, the fastest-growing segment by percentage. In California, CBN-containing edibles went from 4% of the edible category in 2020 to ~25% in 2025 — a 525% share increase. Sleep is the dominant use case.

Treez platform (~400 orgs): CBD-classified products are a small slice overall, but Topical has 12.6% CBD classification (highest of any category) and Tincture has 9.1% CBD — consistent with the minor-cannabinoid wellness positioning. Pill/capsule category has 5.9% CBD, reflecting sleep and wellness formats. (Minor cannabinoids like CBN and THCV often get tagged as "CBD" in org taxonomies because there's no dedicated classification — the real penetration of CBN/THCV products is almost certainly higher than these numbers show.)

Named positioning:

  • CBN: Sleep products — "Mary's Medicinals" (144 orgs, 34.9% penetration), "Level" (192 orgs, 46.5%) both lean into CBN/ratio formulations.
  • THCV: Appetite-suppression "diet weed" — niche but growing, mostly in vape and tincture formats.
  • CBG: Anti-inflammatory positioning — growing in topicals (Papa & Barkley, 158 orgs, 38.3%) and tinctures.

Category outlook: Minor cannabinoids remain category-defining more than revenue-defining — the narrative is shifting from "more THC" to "targeted effects." Sleep, focus, and recovery formats are the near-term growth vectors. (See cannabinoids.md for cannabinoid profiles.)

Cartridge Format Shift: All-In-One Surpasses 510 Thread [Rising]

This subsection is entirely Treez-data-driven. On the Treez platform in March 2026, All-In-One cartridges surpassed 510 Thread as the #1 cartridge format:

| Cartridge Subtype | Revenue Share | Direction | |-------------------|---------------|-----------| | All-In-One | 37.2% | [Rising] -- now #1 | | 510 Thread | 31.1% | [Declining] -- lost top spot late 2025 | | Pod | 13.8% | [Stable] | | Ready To Use | 10.3% | [Stable] | | Cartridge-General | ~7% | [Stable] |

Source: Treez platform (~400 orgs), March 2026 monthly revenue mix.

Driver: Convenience. All-In-One disposables require no battery, no charging, no hardware compatibility decisions. The shift tracks with cannabis's broader "reduce friction" trend — single-serve beverages, pre-packs, infused prerolls are all the same theme. Cartridge overall is 28% of platform revenue and growing share against flower.

Named brands:

  • STIIIZY — $4.5M/month platform revenue (the largest brand by monthly revenue), pod-format leader, 259 orgs (62.7% penetration).
  • RAW GARDEN — $3.5M/month, 113,499 products (deepest catalog of any brand), 189 orgs (45.8% penetration).
  • ROVE — 224 orgs (54.2% penetration), 20,339 products. All-In-One and pod formats.
  • HEAVY HITTERS — 205 orgs (49.6% penetration). 510 and All-In-One portfolio.

Brief Coverage: Supporting Trends

  • Nano-emulsion technology [Emerging]: Enables faster onset (15-20 minutes vs. 60-90 minutes for traditional edibles). Powering the beverage and functional-edible category growth — the shorter onset is a prerequisite for alcohol-substitution positioning (you can't wait 90 minutes at a dinner party).

  • Functional microdose formats [Rising]: 42% of edible consumers prefer ≤10mg THC per occasion (industry survey data). 2mg and 5mg single-serve gummies, beverages, and chocolates are the fastest-growing edible subsegment within low-dose. Kiva, Wyld, and Camino all have low-dose lines. On Treez, Camino (241 orgs, 58.4% penetration) is one of the top-15 brands by reach.

  • Topicals evolution [Stable]: Minor-cannabinoid infusions (CBG anti-inflammatory, CBN muscle recovery), transdermal patches (Mary's Medicinals, Papa & Barkley). Topical is 73.4% unclassified on Treez — the category still struggles with taxonomy, but wellness-positioned brands are anchoring the segment.

  • Pre-Pack dominance [Stable]: Treez data shows Pre-Pack Flower = 80.1% of flower revenue (Pre-Pack 22.7% of all products on the platform, Pre-Pack Smalls 6.8%, Bulk Flower 6.1%). The flower category has almost fully shifted to pre-packaged formats — bulk/deli flower is a niche play (116 orgs vs. 392 for Pre-Pack). This is a freshness/consistency/speed-of-service trend that has already largely played out.

3. Strain Trends

Per plan decisions, strain trends use a dual structure: lineage family analysis (the "why" behind patterns) plus individual hot strain data grounded in Treez org-penetration (the "what's actually in dispensaries").

Lineage Families

Modern cannabis genetics are dominated by a handful of lineage families. Understanding the family explains why so many trending strains "taste similar" — they share DNA.

| Family | Foundational Cross | Notable Descendants | Commercial Impact | Direction | |--------|-------------------|---------------------|-------------------|-----------| | Runtz | Zkittlez × Gelato | White Runtz, Pink Runtz, Runtz Muffin, Obama Runtz | Broad commercial appeal, consistent expression, candy-forward flavor | [Rising] | | Gelato | Sunset Sherbet × Thin Mint GSC | Cap Junky (35%+ THC), Gelonade, Gelato 33, Gelato 41 | Reliable potency, dense structure, bag appeal | [Stable] | | Cookies | OG Kush × Durban Poison (GSC root) | Wedding Cake, Biscotti, London Pound Cake, GMO | Brand-amplified genetics via Cookies retail footprint | [Stable] | | Zkittlez | Grape Ape × Grapefruit | Zkittlez Cake, feeds into Runtz lineage | Flavor-forward, parent to Runtz | [Stable] | | OG Kush | West Coast foundational genetics | SFV OG, Tahoe OG, Fire OG, GMO (via Chem lineage) | Legacy premium status, gas/diesel profiles | [Stable] |

Takeaway: Runtz is the most commercially active family in 2026 — nearly every trending novelty strain has some Runtz or Gelato in the cross. Cookies and OG represent the "classic" tier that anchors menus but has ceded novelty leadership. (Cross-ref strains.md for strain profile detail.)

Top Strains: What Dispensaries Actually Stock

The Treez platform's org-penetration data is the closest thing to ground truth on strain popularity available. This is not "what Leafly wrote about this week" — it's what dispensaries actually put on shelves across ~400 orgs:

| Strain | Classification | Org Count (Treez) | Primary Format | Trend | |--------|---------------|-------------------|----------------|-------| | Blue Dream | Sativa | 69+ | Cartridge, Flower, Preroll | [Stable] -- legacy staple | | GMO | Indica | 53+ | Flower, Preroll, Cartridge | [Stable] | | Strawberry Cough | Sativa | 53+ | Cartridge | [Stable] | | Northern Lights | Indica | 52+ | Cartridge | [Stable] -- legacy | | Pineapple Express | Hybrid | 48+ | Cartridge | [Stable] | | Super Lemon Haze | Sativa | 47+ | Cartridge | [Stable] | | Sour Diesel | Sativa | 46+ | Cartridge | [Stable] | | Lemon Cherry Gelato | Hybrid | 45+ | Cartridge | [Rising] -- Seed Junky | | Green Crack | Sativa | 44+ | Cartridge | [Stable] | | Cereal Milk | Hybrid | 42+ | Multiple | [Rising] |

Source: Treez platform (~400 orgs), May 2025 - March 2026 aggregate. Org count = number of dispensaries with at least one active product matching the strain name.

Interpretation: The org-penetration list skews toward established, broadly available strains. Blue Dream, GMO, Northern Lights, and Sour Diesel are on the list because they've been on dispensary shelves for a decade. Newer trending strains (Permanent Marker, Cap Junky, Jealousy) have lower penetration but faster growth velocity — they are ascending to this list, not already on it. Cartridge is the dominant format in the top 10 because cartridges inherit strain branding most effectively (one strain = one SKU).

Currently Hot Strains

Strains with genuine momentum in 2026. Some are already broadly stocked (Lemon Cherry Gelato); others are still scaling (Permanent Marker, Cap Junky). Direction indicators reflect strain-level trajectory, not absolute penetration:

  • Biscotti [Rising] — Indica-leaning hybrid, Connected Cannabis, premium flower and concentrate anchor.
  • Permanent Marker [Rising] — Seed Junky creation, Runtz × Biscotti × Jet Fuel Gelato, growing dispensary presence.
  • Lemon Cherry Gelato [Rising] — Seed Junky refinement, viral social media, already at 45+ Treez orgs.
  • Purple Runtz [Stable] — Consistent 29% THC, smooth effects, broad appeal.
  • Cap Junky [Rising] — Gelato lineage (Alien Cookies × Kush Mints × Jet Fuel Gelato), tops 35% THC.
  • Wedding Cake [Stable] — Established premium, Seed Junky signature, anchor menu item.
  • Gary Payton [Rising] — Cookies collaboration (Y Griega × Snowman), sativa-dominant hybrid.
  • Jealousy [Rising] — Sherbinski × Seed Junky, Leafly SOTY 2022 alum still gaining org share.
  • Zushi [Rising] — Jungle Boys original, Kush Mints × Z influence.
  • RS11 (Rainbow Sherbet 11) [Rising] — Wizard Trees, exotic/colorful bag appeal.
  • Gelonade [Stable] — Lemon Tree × Gelato 41, citrus-forward, stable menu fixture.
  • Grape Gasoline [Rising] — Grape Pie × Jet Fuel Gelato, gas + fruit flavor combo.
  • Apples & Bananas [Stable] — Compound Genetics, terpene-forward, broad stocking.
  • White Truffle [Rising] — Gorilla Butter F2 phenotype, earthy/gas profile.
  • Papaya Bomb [Emerging] — Tropical flavor niche, newer to dispensary shelves.
  • MAC 1 (Miracle Alien Cookies) [Stable] — Established potent hybrid.
  • Runtz [Stable] — Still a top-selling parent strain, broadly stocked.
  • Oreoz [Rising] — Cookies × Secret Weapon, chocolate-profile niche growing.
  • Pink Runtz [Stable] — Runtz phenotype, strong cartridge performance.
  • Garlic Breath [Stable] — Chemdog × GMO, gas/savory profile, concentrate favorite.

(Cross-ref strains.md for detailed strain profiles, effects, and lineage diagrams.)

Classification Trends

Treez data (platform-wide): Hybrid dominates across all cannabis categories among products that are classified. For Flower, the split is ~22% Hybrid, 16% Indica, 11% Sativa among the ~55% of products that have a classification assigned. The remaining 40-73% of products lack classification entirely — a catalog completeness gap more than a consumer preference signal.

Classification fill rates by category (Treez, March 2026):

| Category | Unknown Classification | Notes | |----------|-----------------------|-------| | Topical | 73.4% | Worst fill rate; minor-cannabinoid topicals don't fit Indica/Sativa taxonomy | | Beverage | 65.1% | Most beverages are Hybrid when classified, but taxonomy mismatch is widespread | | Tincture | 62.9% | Similar to topicals — functional framing beats strain framing | | Edible | 51.3% | Brand formulations often effect-based (sleep, focus), not strain-based | | Extract | 49.6% | Better than edibles; single-strain rosins/resins improve fill | | Pill | 48.2% | Medical formulations | | Flower | 45.4% | Best-in-class but still nearly half unclassified | | Preroll | 40.1% | Strain branding naturally drives classification | | Cartridge | 41.2% | Strain-named carts improve fill |

Takeaway: The "Indica vs. Sativa is outdated" debate is well-documented in industry discussion, but consumers continue to make purchase decisions using those labels. The pragmatic view: the labels persist in merchandising and always-on routing, but terpene-forward marketing (limonene for energy, myrcene for sedation, caryophyllene for relaxation) is the emerging alternative that bridges the gap for educated buyers. Dispensaries with better catalog hygiene (higher fill rates) see meaningfully better basket attach on classification-based recommendations.

4. Breeder Ecosystem

Approximately 100 leading breeders drive the genetics that become next year's dispensary menus. It's a ~$60B downstream industry built on pollination-room decisions. Breeder-as-brand has become a real market force — genetics houses command shelf space and consumer trust in ways that were rare a decade ago.

Seed Junky Genetics [Rising]

LA-based refinement specialists. Created Wedding Cake, Kush Mints, Permanent Marker, Lemon Cherry Gelato. Their methodology: take legendary genetics and improve them through successive phenotype selection. Dominant in West Coast premium market and licensed cultivation. Treez signal: Lemon Cherry Gelato is already at 45+ Treez orgs — a leading indicator of breeder-driven menu change. Strains coming out of Seed Junky become "ones to watch" for retail buyers 6-12 months ahead of mainstream demand.

Compound Genetics [Stable]

Known for exotic flavors, eye-catching colors, rare crosses. Signature releases: Apples & Bananas, Grape Gasoline, Jet Fuel Gelato. Focus on bag appeal and terpene profiles — the "exotic" movement in cannabis owes much of its current aesthetic to Compound. Their genetics dominate the premium indoor flower segment in California and are expanding nationally through licensed partnerships.

Cookies / Berner [Stable]

The business model: genetics + retail + brand. ~12 state retail presence, GSC lineage empire (Wedding Cake, Biscotti, Cereal Milk, Gary Payton). Treez signal: COOKIES brand is at 178 orgs (43.1% penetration) with 11,483 products — one of the most widely distributed cannabis-specific brands on the platform. Their retail footprint means Cookies-bred strains get in-house distribution advantage plus broad wholesale distribution. The model is replicated but rarely matched.

Connected Cannabis [Stable]

Created Biscotti. California premium market leader with vertical integration (genetics, cultivation, retail). Treez signal: CONNECTED at 149 orgs (36.1% penetration), 11,575 products. Known for Gelato 41 phenotype stewardship and ongoing Biscotti line extensions. Premium positioning with consistent pricing power — Connected flower commonly sits above $50/eighth at retail.

Archive Seeds [Stable]

Oregon-based. Deep catalog focused on genetic preservation and rare variety access. Longer pollination-cycle approach than most commercial breeders — the catalog is broad but moves slowly. Popular with home growers and connoisseur cultivators seeking stabilized, less-commercial phenotypes. Market signal more than revenue driver.

Jungle Boys [Rising]

Vertical integration at scale: genetics + cultivation + retail. CA premium market leader expanding into FL and other markets. Created and stewards Zushi, Hippy Crasher, Gelato 41 phenotypes. Brand recognition drives premium pricing (their flower regularly commands 30%+ price premium over comparable indoor).

Other Notable Breeders

  • Symbiotic Genetics — GMO and Wedding Cake lineage contributions, clone/cut availability focus.
  • 3rd Gen Family / Wizard Trees — RS11 and novel color-expression work, exotic niche.
  • Grandiflora — Runtz family stewardship and LA premium positioning.
  • Ethos Genetics — Denver-based, extensive catalog with strong medical and ratio genetics work.
  • Exotic Genetix — Washington-based (Mike Russo), award-winning crosses (Kush Mints, Tropicana Cookies).
  • Humboldt Seed Company — Large-scale breeder with broad commercial distribution.

(Cross-ref strains.md Breeders section for extended breeder directory and signature strain details.)

Industry structure note: Breeder influence is concentrated at the top — the top ~100 breeders drive most of what shows up in dispensary menus. Breeder-brand-retailer integration (Cookies, Jungle Boys, Connected) is the highest-leverage model because it captures genetics, cultivation, and retail margin in one stack.

5. Brand Momentum

Treez first-party data reveals which brands are winning by which metric. The definition of "winning" depends on what you're optimizing for:

| Metric | Leader | Value | Why It Matters | |--------|--------|-------|----------------| | Org Penetration | WYLD | 77.0% (318 orgs) | Broadest distribution = strongest brand pull. Edibles brand that has become ubiquitous. | | Monthly Revenue | STIIIZY | ~$4.5M | Volume king with heavy discounting (34.6% avg discount rate). Cartridge-led. | | SKU Breadth | RAW GARDEN | 114,447 variants | Deepest catalog of any brand. Cartridge + flower portfolio breadth. | | Premium Positioning | CAM | $52.25 avg price | Premium flower at highest average price among top-50 brands, with 36% discount rate (still-discounted premium). | | Growth Category Leader | JEETER | ~$3.0M preroll revenue/month | Riding the infused preroll wave — clearest category-specific dominance. | | Non-Cannabis Cross-Sell | RAW (papers) | 70.2% (290 orgs) | Accessory brand at 2nd-highest platform penetration — accessory cross-sell is a real revenue stream. |

Source: Treez platform (~400 orgs), May 2025 - March 2026 aggregate.

Non-cannabis brands in the top 50 penetration list: RAW (70.2%, rolling papers), BIC (53.8%, lighters), PUFFCO (51.6%, hardware/batteries), ZIG ZAG (41.6%, papers/wraps), BLAZY SUSAN (36.8%, papers), CLIPPER (32.7%, lighters), KING PALM (31.7%, natural wraps). The presence of 7 non-cannabis brands in the top 50 tells retailers that accessory cross-sell is a live revenue stream most dispensaries under-merchandise — these brands aren't on shelves by accident.

Brand archetypes and their winning strategies:

  • Volume-with-discount (STIIIZY, JEETER): High monthly revenue powered by depth, breadth, and willingness to discount aggressively (30%+). Works in mature markets with price-sensitive consumers.
  • Broad-distribution edibles (WYLD, KIVA, CAMINO): Ubiquity via gummy + chocolate breadth. WYLD's 77% penetration is the highest on the platform.
  • Premium flower (CAM, Alien Labs, Connected, Jungle Boys): High price per unit, lower discount resistance, concentrated in premium-positioned stores.
  • Concentrate specialist (710 LABS, NASHA): Deep in solventless, moderate penetration, strong connoisseur pull.
  • Beverage specialist (CANN, KEEF, UNCLE ARNIE'S): Category-focused, lower overall revenue but high unit velocity.

(Cross-ref brands.md for brand profiles, MSO breakdowns, and non-cannabis accessory brand analysis.)

6. Legalization Pipeline

Federal first per Phase 11 D-14, then state pipeline with directional likelihood tiers. All claims dated to early 2026.

Federal Status

Trump Executive Order on Rescheduling (Dec 18, 2025): The EO directs the DOJ to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. DOJ formal rulemaking has been initiated, but the process is complex — final rule completion is unlikely before 2027 and could slip further. Cannabis remains Schedule I as of early 2026.

What Schedule III would change:

  • 280E tax elimination — the single biggest economic impact. Current 280E disallows standard business-expense deductions for Schedule I/II businesses; moving to Schedule III lifts that restriction. See references/280e.md §Under Schedule III for the operator-level economic-impact estimate.
  • Research access — reduced DEA barriers to federally-approved cannabis research.
  • Banking — partial easing; Schedule III does not fully resolve banking hesitancy but reduces some compliance overhead.

What Schedule III does NOT change:

  • Rescheduling ≠ legalization. Recreational cannabis businesses without DEA Schedule III registration remain federally illegal. Only FDA-approved Schedule III drugs can be legally prescribed.
  • Interstate commerce — still prohibited until full de-scheduling or a separate federal interstate framework.
  • State law supremacy — states continue to control adult-use markets; no federal adult-use framework follows from rescheduling alone.

SAFE Banking Act: Passed the House multiple times (2019-2023); SAFER Banking Act reintroduced in 2026 with 14 Senate cosponsors (as of 2026-04). Committee-stalled despite 32-state-AG letter of support in 2025. Operators should not plan on passage in near-term treasury or capital planning.

For full SAFE Banking detail — current bill status, operator implications, SAFER variants, and the cannabis-banking institutional landscape — see references/banking.md §SAFE / SAFER Banking Act — Canonical Home.

Interstate Commerce Analysis [Dedicated per D-16]

Interstate commerce is the single structural change that would most reshape the US cannabis industry. If/when enabled, the directional impact:

  • CA oversupply floods other state markets. CA has ~3x the cultivation capacity of in-state demand (various industry estimates). Interstate commerce exports that oversupply to higher-priced markets.
  • Race to the bottom on pricing. Mature-market prices converge toward CA wholesale levels within 6-24 months of interstate opening. Premium positioning fragments — some brands hold price, most don't.
  • Brand nationalization. MSOs and well-capitalized craft brands build national distribution; regional-only brands face existential pressure. The brand consolidation that has slowly happened within states over the past 5 years compresses into 2-3 years at national scale.
  • Price convergence across states. CA, OR, MI, CO (oversupplied) export downward; NY, NJ, PA, OH (undersupplied) import downward price pressure. The state-by-state price dispersion seen in pricing.md compresses significantly.

Timeline framing: Highly uncertain. Most likely paths: (a) full federal de-scheduling (low probability near-term), (b) an interstate commerce framework bill (higher probability as states press for it), (c) state compacts under DOJ non-enforcement tolerance (possible but legally fragile). Industry leaders frame interstate commerce as a "tailwind, not a lifeline" — directionally beneficial for scaled operators, disruptive for regional players.

Scenario planning, not prediction: Frame interstate commerce discussions as "if/when it opens" rather than a dated prediction. Operators should stress-test their pricing strategy against a 20-30% wholesale price decline to understand exposure.

State Pipeline (Directional Likelihood Tiers)

Per D-15, group states into Likely (1-2 years), Possible (3-5 years), Unlikely (near-term unlikely). Reasoning per tier, no specific date predictions.

Likely (1-2 years):

  • Pennsylvania — Bipartisan legislative support, governor pushing adult-use, ~56% voter approval in a February 2026 poll. Regulatory framework conversations underway. Most likely next adult-use state.

Possible (3-5 years):

  • Kentucky — Medical expansion with HB 401; adult-use pathway is plausible post-medical-maturity but not imminent.
  • Other medical-only states with growing momentum — MN already adult-use, but NH, NC, GA have periodic legislative activity without clear near-term momentum.

Unlikely (near-term):

  • Florida — FL Supreme Court dismissed a 2026 ballot effort 6-1 in February 2026 with new signature hurdles. Regulatory hostility at the state level makes adult-use unlikely before 2028-2029.
  • Deeply conservative holdout states — TX, TN, KS, AL, ID. Medical expansion is the near-term ceiling.

Active market launches (already legal, scaling):

  • Ohio — SB 56 regulatory referendum in progress, adult-use stores operational, market scaling through 2026.
  • New York — Rapid scaling from ~$100M (2023) to ~$1.8B (2025), #1 growth state 2026. Licensing bottlenecks easing.
  • New Jersey — Continued expansion, consumer demand mature.
  • Vermont, Minnesota — Small markets with steady maturation.

(Cross-ref legality.md for full state-by-state legal status, licensing structures, and compliance requirements.)

Social Equity Trends [Brief per D-17]

Mandatory social equity provisions are [Rising] in new legalization bills. Common elements: license set-asides for equity applicants (by conviction history, zip code, or ownership), technical-assistance funds, and community-reinvestment revenue allocation. Execution quality varies widely state-to-state — some programs (IL, MA) have delivered meaningful equity licensing; others (NY initial rollout) faced implementation challenges. The policy trend is clear, the execution outcomes are mixed.

(Cross-ref Phase 14 business operations for equity-program compliance detail.)

7. Market Projections

Multi-source ranges per D-18. Present estimates, not predictions. Always cite source and vintage.

National Market Size

Third-party analyst projections (2026-2034):

| Source | Figure | Year | Methodology Note | |--------|--------|------|------------------| | Statista | ~$47B | 2026 projected | Total US legal cannabis revenue estimate | | BDSA | Implied $40-45B | 2025-2026 | Tracking sales in ~15 legal states, extrapolated | | Headset | State-specific tracking | 2025 actuals | Focuses on tracked states, not national total | | Renub Research | $11.73B → $40.41B | 2025 → 2034 | 14.73% CAGR projection, narrower base definition | | New Frontier Data | Various | Rolling | Broader TAM including illicit + adjacent markets | | MJBizDaily Factbook | ~$30-35B | 2025 estimated | Conservative legal-only estimate |

Treez platform context: The Treez platform processes ~$200M/month across ~345 active orgs — annualized to roughly $2.4B/year. Treez's customer base represents ~5% of the estimated national legal market, concentrated in CA and other mature West Coast / mountain states. This is a large-enough sample to be directionally representative of mature-market dynamics but under-indexes on newly-launched East Coast markets (NY, NJ).

Interpretation: Estimates vary 30-50% between firms because of methodology differences (what counts as "legal cannabis"? which states? adult-use only or + medical?). Present as ranges. The directional story — US legal cannabis is a $30-50B market in 2026 growing at 10-15% CAGR — is well-supported. Specific point estimates are not.

Growth by State (Phase 10 Maturity Tiers)

Using the market-maturity framework from pricing.md:

Fastest growth (newest adult-use markets):

  • New York — #1 growth state 2026. $100M (2023) → $1.8B (2025) as licensing caught up with demand. Continued strong growth projected.
  • Ohio — Adult-use operational, scaling through 2026.
  • New Jersey — Mature but continued growth.
  • Vermont — Small but growing steadily.
  • Minnesota — Market just maturing.

High historical growth (scaling markets):

  • Arizona — +580% projected 2021-2026 from a small adult-use base.
  • Illinois — +426% same period; market now maturing.
  • Missouri, Montana — Medium-tier growth through maturity phase.

Mature/saturated (stable or softening):

  • Oregon, Colorado — Stabilized; wholesale prices depressed; oversupply easing slowly.
  • California — Recovering from oversupply; illicit-market competition remains a structural drag.
  • Washington, Nevada — Mature; growth tracks macro retail trends.

(Cross-ref legality.md for state legal status and pricing.md for maturity tier definitions and pricing dispersion.)

Growth by Category

Pair industry growth rates with Treez first-party share data:

| Category | Industry YoY Growth | Treez Platform Share | Treez Interpretation | |----------|--------------------|-----------------------|----------------------| | Pre-rolls | +12% YoY (highest CAGR ~10%) | 16% revenue share | Infused format driving growth; matches industry narrative | | Beverages | +11% YoY | 1.5% revenue share | Small base, steady MoM growth $2.7M → $3.3M over 11 months | | Cartridges | Vape overtook flower in CA late 2025 (BDSA) | 28% revenue share, approaching flower | Treez confirms structural shift now platform-wide, not just CA | | Concentrates overall | $1.6B (2025) → $6.8B (2035), 15.7% CAGR (projected) | 5% revenue share | Live Rosin niche within is the highest-momentum subsegment | | Flower | Declining share industry-wide | 33% revenue share, down from higher share | Still largest by revenue but losing share to vape + preroll | | Edibles | Steady; low-dose functional subsegment outperforming | 10% revenue share | Stable; beverages growing within broader edible/consumable bucket |

(Cross-ref pricing.md for category-level price dispersion and retail-strategy.md for category mix targets by store type.)

8. Seasonal Forecasting

Treez first-party data provides real platform-wide multipliers for seasonal peaks — a level of specificity most public reports cannot match. Pair this with industry seasonal narratives and inventory prep triggers.

Seasonal Calendar with Treez Platform Multipliers

| Event | Date | Treez Platform Impact | Top Category Lift | Inventory Prep Trigger | |-------|------|-----------------------|-------------------|------------------------| | 4/20 | April 20 | 2.17x daily revenue ($11.96M vs. $5.5M avg baseline) | Flower, Pre-Rolls (+90% industry) | March: stock flower + prerolls aggressively, vendor holds, staff scheduling | | July 4th Weekend | July 3-5 | 1.62x on July 3 (pre-holiday stock-up, $8.90M) | Broad | June: increase all core categories, party-pack prerolls | | 7/10 (Dab Day) | July 10 | Concentrate spike (smaller than 4/20 but category-concentrated) | Extract, Live Rosin | June: concentrate inventory depth, sample programs | | Green Wednesday | Wed before Thanksgiving | Strong (surpassed 4/20 in 2020 per industry sources) | Broad | Early November: broad category build, family-gathering positioning | | Christmas Eve | Dec 24 | 1.66x ($9.10M) | Edibles (+6.7%), Topicals (+17%) | October: begin holiday build, edibles gift-positioning, topicals for wellness-gifting | | New Year's Eve | Dec 31 | 1.56x ($8.59M) | Broad, party-oriented | November: party-pack prerolls, beverages, social-occasion edibles | | Post-4/20 Monday | April 21 | -24% "hangover" | Broad decline | Plan staff/orders around demand drop |

Source: Treez platform (~400 orgs), May 2025 - March 2026 aggregate. Multipliers are versus baseline daily platform revenue (~$5.5M/day average).

Monthly Rhythm (Treez Data)

Beyond single-day peaks, the Treez platform shows clear monthly patterns:

  • September dip [predictable]: all categories drop 5-10% MoM in September (post-summer slowdown, back-to-school, travel normalization). Reduce order depth ~5-10% vs. August to avoid dead-stock accumulation.
  • October rebound [predictable]: 8-15% recovery across the board as consumers re-engage. Build inventory back up for Croptober harvest releases (see inventory-planning.md) and Halloween-edible lift.
  • November (Thanksgiving week): Green Wednesday drives the peak; November overall is a strong month.
  • December surge: Edible +6.7%, Topical +17% — the gifting categories over-index. Holiday revenue concentrates in the last two weeks.
  • January/February trough: -4% to -7% vs. November — lowest revenue months of the year. Dry January has a measurable effect; tax-season budget pressure compounds it.
  • March recovery: 5-10% bounce as 4/20 approach drives vendor pushes, promos, and consumer replenishment.
  • April: 4/20 is the single largest revenue day; the rest of the month is strong.

Inventory Prep Triggers (Month-by-Month)

Aligning Treez platform data with the inventory-planning.md retail playbook:

  • January-February: Lean inventory; clear Q4 holiday leftovers; evaluate dead stock.
  • March: 4/20 build begins. Lock vendor allocations for flower, prerolls, cartridges. Staff scheduling for 4/20 Saturday.
  • April 1-20: Peak-stock week; expect 24/7 rushes on 4/20 weekend.
  • April 21-30: Post-4/20 discount clearance; carry minimal excess.
  • May-June: Summer tourism build (in tourism states); 7/10 concentrate inventory by end of June.
  • July: 4th weekend and 7/10 peaks; restock fast.
  • August: Steady; begin planning fall catalog.
  • September: Reduce orders 5-10%; don't over-buy.
  • October: Holiday build starts; Croptober flower releases; edible gift-packaging in.
  • November: Green Wednesday peak; Thanksgiving week is the highest sustained 7-day period.
  • December: Holiday gift-positioning, party-pack prerolls, low-dose beverages for NYE.

(Cross-ref inventory-planning.md for detailed month-by-month inventory playbook and reorder-point heuristics.)

9. Price Trend Directions

Macro only per D-21. For detailed price ranges, state maturity tiers, and category-level benchmarks, see pricing.md.

Treez platform price percentiles (March 2026, ground truth):

| Category | P25 | Median | P75 | P90 | Interpretation | |----------|-----|--------|-----|-----|----------------| | Flower | $12.47 | $24.49 | ~$38 | $54.23 | Wide range reflects premium/value stratification | | Cartridge | ~$15 | $20.88 | ~$28 | ~$40 | Relatively tight pricing — commoditization proceeding | | Preroll | $3.75 | $8.07 | ~$15 | ~$28 | High-volume singles pulling average down | | Edible | ~$7 | $11.67 | ~$20 | ~$35 | Broad range: single-serve to large-pack | | Beverage | ~$5 | $6.46 | ~$9 | ~$14 | Impulse-purchase pricing | | Extract | ~$10 | $15.99 | ~$30 | ~$55 | Premium solventless pulls P90 up |

Source: Treez platform (~400 orgs), March 2026 median product prices by category.

Macro price trend directions:

  • Race to the bottom in mature markets [Rising pressure]: CA, OR, CO, WA wholesale flower prices continue their multi-year decline. Retail prices in these markets compress accordingly. Interstate commerce would amplify this pressure nationally.
  • Premium pricing power holds in emerging markets [Stable]: NY, NJ, OH maintain high retail prices while supply catches up to demand. Premium positioning commands 20-30% higher margins vs. mature markets (as of 2025-2026).
  • Cartridge price convergence [Stable]: Cartridge pricing is tightening — the P90-to-P25 spread has narrowed in Treez data over the 11-month observation window, consistent with commoditization.
  • Preroll bifurcation [Rising]: Infused prerolls hold premium pricing; flower-only prerolls are discount-driven. The category splits price-wise more than it did 18 months ago.
  • Beverage impulse-price anchor [Stable]: Median $6.46 per unit holds — the category has settled into impulse-single-serve pricing with modest variance.

(Cross-ref pricing.md for state-tier pricing detail, wholesale vs. retail dynamics, and margin benchmarks.)

10. Consumer & Technology Shifts

Brief coverage per D-22. Adjacent to but not central to market intelligence.

Basket-level consumer signals (Treez platform):

  • AOV $44-46, median $33, 2.7 items/basket, 1.4 categories/basket — most consumers are single-category shoppers per visit.
  • Top cross-category pairing: Cartridge + Preroll (5.7% of all baskets) — these two categories co-occur more than any other pair. Positioning them adjacent in the menu or as combo-promos captures incremental revenue.
  • Beverage + Edible co-purchase (1.4% of baskets) — a "consumption-oriented buyer" segment; smaller but distinct.
  • Flower + Preroll (~4% of baskets) — the "stock up" shopper; larger average basket when it occurs.

Technology shifts [Brief]:

  • Online ordering share [Rising]: Pre-order / reserve-online has become table stakes; order-ahead is the default for many frequent consumers.
  • Delivery adoption [Rising]: Legal in a growing number of states (CA, MA, MI, NM, NV, OR, others); delivery-only / dark-store models maturing in CA.
  • AI product recommendations [Emerging]: Effect-based and terpene-based recommendation engines (integrated in dispensary e-commerce) are replacing strain-only navigation. Better at bridging the Indica/Sativa-is-outdated gap for consumers.
  • Social media discovery [Rising]: TikTok, Instagram, and cannabis-specific platforms (Jointly, Weedmaps social) drive strain and brand awareness — especially for younger consumers (21-35).
  • Loyalty programs [Stable]: Widely adopted; effectiveness varies dramatically with execution quality. Top-quartile programs drive 20-30%+ repeat-visit lift.

(Cross-ref Phase 13 for cannabis technology platforms and e-commerce detail, and retail-strategy.md for merchandising implications.)

Notes on Framing

  • This reference is market intelligence, not investment advice. Everything here is framed as what the market is doing, not what anyone should buy or sell. Operators, investors, and consultants all use this reference for directional understanding; decisions stay with the decision-maker.
  • Estimates are ranges, not point forecasts. Market size, CAGR, and category growth figures always carry source attribution and vintage dates. Interstate commerce and rescheduling timelines are scenario framings, not predictions.
  • Trend direction indicators age better than specific multipliers. A "[Rising]" tag on infused prerolls will remain accurate longer than "46.3% of preroll revenue in March 2026." When this file is 6+ months old, lean on direction indicators and recommend a fresh Headset/BDSA/Treez pull for the specific figures.
  • First-party data is what makes this reference uniquely useful. Industry reports can be sourced from Headset, BDSA, or Flowhub public briefings. The Treez platform-level data (strain org-penetration, category revenue shares, seasonal multipliers, brand monthly revenue) is a different data class — it's what dispensaries actually processed, not what the industry talked about.